NO20014987L - Substituerte azoler - Google Patents

Substituerte azoler

Info

Publication number: NO20014987L
Authority: NO; Norway
Prior art keywords: substituted azoles; azoles; substituted
Prior art date: 1999-04-14

Application number

NO20014987A

Other languages

English (en)

Norwegian (no)

Other versions

NO20014987D0 (no

Inventor

Laszlo Revesz

Achim Schlapbach

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2001-10-12

Publication date

2001-12-14

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

2001-10-12 Application filed by Novartis Ag filed Critical Novartis Ag

2001-10-12 Publication of NO20014987D0 publication Critical patent/NO20014987D0/no

2001-12-14 Publication of NO20014987L publication Critical patent/NO20014987L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

NO20014987A 1999-04-14 2001-10-12 Substituerte azoler NO20014987L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (fr)	1999-04-14	2000-04-12	Azoles substitues

Publications (2)

Publication Number	Publication Date
NO20014987D0 NO20014987D0 (no)	2001-10-12
NO20014987L true NO20014987L (no)	2001-12-14

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014987A NO20014987L (no)	1999-04-14	2001-10-12	Substituerte azoler

Country Status (25)

Country	Link
US (1)	US6579874B2 (fr)
EP (1)	EP1224180B1 (fr)
JP (1)	JP2003503311A (fr)
KR (1)	KR20010108504A (fr)
CN (1)	CN1378544A (fr)
AR (1)	AR023465A1 (fr)
AT (1)	ATE244236T1 (fr)
AU (1)	AU4295300A (fr)
BR (1)	BR0010598A (fr)
CA (1)	CA2370417A1 (fr)
CO (1)	CO5170501A1 (fr)
CZ (1)	CZ20013696A3 (fr)
DE (1)	DE60003709T2 (fr)
DK (1)	DK1224180T3 (fr)
ES (1)	ES2202114T3 (fr)
HU (1)	HUP0302747A2 (fr)
IL (1)	IL145836A0 (fr)
MX (1)	MXPA01010434A (fr)
NO (1)	NO20014987L (fr)
PE (1)	PE20010031A1 (fr)
PL (1)	PL364789A1 (fr)
PT (1)	PT1224180E (fr)
SK (1)	SK14562001A3 (fr)
TR (1)	TR200102967T2 (fr)
WO (1)	WO2000063204A2 (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE396978T1 (de)	1999-10-07	2008-06-15	Amgen Inc	Triazin-kinase-hemmer
JP2003512467A (ja)	1999-10-27	2003-04-02	ノバルティスアクチエンゲゼルシャフト	チアゾールおよびイミダゾ（４，５−ｂ）ピリジン化合物ならびにそれらの医薬用途
AU3704101A (en) *	2000-02-17	2001-08-27	Amgen Inc	Kinase inhibitors
US7105530B2 (en)	2000-12-21	2006-09-12	Smithkline Beecham Corporation	Pyrimidineamines as angiogenesis modulators
CA2436739A1 (fr) *	2000-12-26	2002-07-04	Takeda Chemical Industries, Ltd.	Agent de combinaison
EP1364949A4 (fr)	2001-02-02	2005-11-23	Takeda Pharmaceutical	Inhibiteur de jnk
EA200300864A1 (ru)	2001-03-09	2003-12-25	Пфайзер Продактс Инк.	Триазолопиридины в качестве противовоспалительных средств
DE60207390T2 (de) *	2001-03-09	2006-07-20	Pfizer Products Inc., Groton	Entzündungshemmende benzimidazolverbindungen
EP1247810B1 (fr)	2001-04-04	2005-09-07	Pfizer Products Inc.	Nouveaux benzotriazoles avec un effet anti-inflammatoire
WO2002100433A1 (fr) *	2001-06-11	2002-12-19	Takeda Chemical Industries, Ltd.	Compositions medicinales
TWI231757B (en)	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
JP4313671B2 (ja)	2001-09-21	2009-08-12	ソルベイ・フアーマシユーチカルズ・ベー・ブイ	Ｃｂ１−拮抗活性を有する新規４，５−ジヒドロ−１ｈ−ピラゾール誘導体
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
US20040259917A1 (en) *	2001-12-19	2004-12-23	Cosford Nicholas D.P.	Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
JP2005538066A (ja)	2002-07-09	2005-12-15	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規な抗コリン作用薬及びｐ３８キナーゼ阻害剤を用いた新規な医薬組成物
US20040132726A1 (en) *	2002-08-09	2004-07-08	Astrazeneca Ab And Nps Pharmaceuticals, Inc.	New compounds
CA2495179A1 (fr)	2002-08-09	2004-02-19	Astrazeneca Ab	Nouveaux composes
CN1894241A (zh)	2002-08-09	2007-01-10	阿斯利康(瑞典)有限公司	作为代谢型谷氨酸受体－5调节剂的“1,2,4” 噁二唑
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
CA2496812A1 (fr) *	2002-08-30	2004-03-11	Pfizer Products Inc.	Nouveaux procedes et produits intermediaires pour preparer des triazolo-pyridines
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
ATE457716T1 (de)	2002-12-30	2010-03-15	Angiotech Int Ag	Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
EP1591443B1 (fr)	2003-02-07	2010-08-25	Daiichi Sankyo Company, Limited	Derive de pyrazole
BRPI0407384A (pt)	2003-02-14	2006-02-21	Pfizer Prod Inc	piridinas-triazóis como compostos antiinflamatórios
TWI326282B (en) *	2004-04-28	2010-06-21	Mitsubishi Tanabe Pharma Corp	Heterocyclic compound
CN1980901A (zh)	2004-06-30	2007-06-13	万有制药株式会社	联芳基衍生物
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1988825B1 (fr) *	2006-02-08	2016-12-21	The General Hospital Corporation	Dispositifs et systèmes pour obtenir des informations associées à un prélévement anatomique utilisant la microscopie optique
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
RU2497816C2 (ru)	2007-04-30	2013-11-10	Эббви Инк.	Ингибиторы фермента диацилглицерин о-ацилтрансферазы типа 1
EP1992344A1 (fr)	2007-05-18	2008-11-19	Institut Curie	P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
JP5581219B2 (ja)	2008-01-25	2014-08-27	ミレニアムファーマシューティカルズ，インコーポレイテッド	チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用
EP2108641A1 (fr)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	Nouveaux dérivés substitués de spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one et leur utilisation comme ihibiteurs de p38 mitogen-activated kinase
EP2113503A1 (fr)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	Nouveaux dérivés d'indolin-2-one substitués et leur utilisation comme inhibiteurs de p38 mitogen-activated kinase
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
WO2010090716A1 (fr)	2009-01-30	2010-08-12	Millennium Pharmaceuticals, Inc.	Hétéroaryles et applications associées
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
PT2432767E (pt) *	2009-05-19	2013-07-25	Dow Agrosciences Llc	Compostos e métodos para controlo de fungos
EP2322176A1 (fr)	2009-11-11	2011-05-18	Almirall, S.A.	Nouveaux dérivés de 7-phényl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
US8796271B2 (en)	2010-08-11	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
US9062038B2 (en)	2010-08-11	2015-06-23	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
EP2603216A4 (fr)	2010-08-11	2013-12-18	Millennium Pharm Inc	Hétéroaryles et utilisations
EA201390539A1 (ru)	2010-10-13	2013-09-30	Милленниум Фармасьютикалз, Инк.	Гетероарилы и их применение
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
WO2017151409A1 (fr)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Méthodes de chimiothérapie
WO2018159650A1 (fr) *	2017-02-28	2018-09-07	東レ株式会社	Dérivé de guanidine et son utilisation médicinale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1306377A3 (fr) *	1993-11-08	2003-05-07	Smithkline Beecham Corporation	Pyridyl-oxazoles et leur utilisation comme inhibiteurs de cytokines
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
ATE235239T1 (de) *	1995-08-10	2003-04-15	Merck & Co Inc	2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Application Discontinuation
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/fr not_active Application Discontinuation
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 CA CA002370417A patent/CA2370417A1/fr not_active Abandoned
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 EP EP00922630A patent/EP1224180B1/fr not_active Expired - Lifetime
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0302747A2 (hu)	2003-12-29
EP1224180B1 (fr)	2003-07-02
IL145836A0 (en)	2002-07-25
PT1224180E (pt)	2003-11-28
ATE244236T1 (de)	2003-07-15
CO5170501A1 (es)	2002-06-27
TR200102967T2 (tr)	2002-01-21
WO2000063204A3 (fr)	2002-05-23
US6579874B2 (en)	2003-06-17
DE60003709D1 (de)	2003-08-07
BR0010598A (pt)	2002-02-05
EP1224180A2 (fr)	2002-07-24
PE20010031A1 (es)	2001-02-23
SK14562001A3 (sk)	2002-03-05
DK1224180T3 (da)	2003-10-20
CA2370417A1 (fr)	2000-10-26
DE60003709T2 (de)	2004-12-23
MXPA01010434A (es)	2002-03-27
US20020049220A1 (en)	2002-04-25
JP2003503311A (ja)	2003-01-28
WO2000063204A2 (fr)	2000-10-26
AR023465A1 (es)	2002-09-04
ES2202114T3 (es)	2004-04-01
NO20014987D0 (no)	2001-10-12
CN1378544A (zh)	2002-11-06
AU4295300A (en)	2000-11-02
KR20010108504A (ko)	2001-12-07
CZ20013696A3 (cs)	2002-02-13
PL364789A1 (en)	2004-12-13

Legal Events

Date	Code	Title	Description
2004-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1224180T3 (da)	2003-10-20	Substituerede azoler
NO20016115L (no)	2002-02-12	Substituerte heterosykelkondenserte gamma-karbolin
EE200100502A (et)	2002-12-16	Ühendid
DE60040714D1 (de)	2008-12-18	Ewährleisten
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
ATA51899A (de)	2002-04-15	Handstempel
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
ATE360620T1 (de)	2007-05-15	Imidazolderivate
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
DK1070708T3 (da)	2004-05-10	Triazolderivater
DE60018989D1 (de)	2005-04-28	N-carbamoyloxyalkyl-substituierte azolium-verbindungen
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
NO20013769D0 (no)	2001-08-01	Kalsilytiske forbindelser
NO20020466L (no)	2002-03-20	Kalsilytiske forbindelser
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
NO20022927L (no)	2002-06-18	Substituerte pyrrazoler
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
DE10082008D2 (de)	2002-12-19	Ausbeulgerät
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
ATA107599A (de)	2002-06-15	Heizwasserbereiter
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
FI4295U1 (fi)	2000-01-19	Vieroituslaite
AT500658A3 (de)	2007-10-15	Isolierplatte